Clinical manifestations, course variants and complications of Takayasu arteritis in Kyrgyz patients

Objective: to study clinical presentation, course variants and complications of Takayasu arteritis (AT) in Kyrgyz patients.

Patients and methods. 75 Kyrgyz patients with a definite diagnosis of AT were included in the study, most of them were women (93.3%). The median age was 33 [23; 40] years, the median duration of the disease was 7 [3.0; 13.0] years. The anatomical type of vascular lesions was determined using the angiographic classification of R. Moriwaki et al., the AT activity – according to the BVAS index, the clinical stage of AT – using the R. Jefferson classification, the severity and prognosis of the disease – according to the K. Ishikawa classification. Highly sensitivity CRP (hsCRP) was assessed in 44 (58.67%) patients, interleukin 6 (IL6) – in 26 (34.7%). Instrumental procedures included duplex Doppler ultrasonography of peripheral arteries and contrast-enhanced computed pan aortography.

Results and discussion. The mean age of AT onset was 24.4±9.4 years. The majority of patients had V anatomical type of vascular lesions (61.3%), vascular stage (89.3%), severe stenosis (54.7%) with predominant affection of the brachiocephalic trunk (68%), common carotid arteries (53.7 %) and renal (52%) arteries. Most patients (82.7%) at the time of inclusion in the study had a severe exacerbation of AT according to the BVAS index. An increase in hsCRP level was seen in 66% of cases, IL6 – in 31%. At the onset of AT, 20% of patients had fever, general weakness, weight loss, myalgia and/or arthralgia. 43% of patients had ≥2 complications. The clinical manifestations of AT were mainly characterized by cardiovascular pathology (77.3%) with the formation of relative aortic valve insufficiency (AVI) (93.1%) and kidney damage (57.3%) with the development of renovascular arterial hypertension (91%). At the first visit, more than one third of patients (37.3%) had irreversible damage, accompanied in half of them by AVI degree II or III.

Conclusion. Young women predominated among Kyrgyz patients with AT. Most of the patients had anatomical type V AT (61.3%), vascular stage (89.3%), severe stenosis (54.7%), affection of the brachiocephalic trunk (68%), common carotid (57.3%) and renal (52%) arteries. Severe exacerbation of the disease was observed in 82.7% of patients. The presence of ≥2 complications worsened the prognosis of AT. The clinical manifestations of AT were characterized mainly by cardiovascular pathology (77.3%) and kidney damage (57.3%). In more than one third of patients (37.3%) AT was diagnosed late.

1. Jennette J, Falk R, Bacon P, et al. 2012 revised Internatoinal Chappel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.

2. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. doi: 10.1136/jcp.55.7.481.

3. Watts R, Al-Taiar A, Mooney J, et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009 Aug;48(8): 1008-11. doi: 10.1093/rheumatology/kep153. Epub 2009 Jun 19.

4. Volosnikov DK, Glazyrina GA, Serebryakova EN, et al. Non-specific aortoarteritis (Takayasu arteritis) in children and adolescents: literature review and clinical case description. Trudnyi patsient. 2015;(1-2):36-9. (In Russ.).

5. Abularrage CJ, Slidell MB, Arora S. Takayasu disease. Rutherford Vascular Surgery. 2009;78(2):100-6.

6. Darmochwal-Kolarz D, Chara A, Korzeniewski M, et al. Takayasu's arteritis in pregnancy – a case report. Ginekol Pol. 2014 Jan;85(1):62-5. doi: 10.17772/gp/1693.

7. Watanabe R, Ishii T, Nakamura K, et al. Ulcerative colitis is not a rare complication of Takayasu arteritis. Mod Rheumatol. 2014 Mar; 24(2):372-3. doi: 10.3109/14397595.2013.854045.

8. Pokrovskii AV, Kuntsevich GI, Zotikov AE, Burtseva EA. Structural and functional changes in the arterial wall and clinical manifestations of nonspecific aortoarteritis. Angiologiya i sosudistaya khirurgiya. 2009; 15(1):7-16. (In Russ.).

9. Mason JC. Takayasu arteritis – advances in diagnosis and management. Nat Rev Rheumatol. 2010 Jul;6(7):406-15. doi: 10.1038/nrrheum.2010.82.

10. Gudbrandsson B, Garen T, Molberg O, et al. Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data from a Large, Population Based Cohort Resident in Southern Norway. Arthritis Care Res (Hoboken). 2017 Feb;69(2):278-85. doi: 10.1002/acr.22931. Epub 2016 Dec 31.

11. Ryabov SI, Almazov VA, Shlyakhto EV, editors. Rukovodstvo «Vnutrennie bolezni» [Guidelines «Internal diseases»]. SaintPetersburg: SpetsLit; 2000. 861 p.

12. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998 Oct 1;66 Suppl 1:S191-4; discussion S195. doi: 10.1016/s0167-5273(98)00181-8.

13. Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Intern Med. 2011 Oct 4; 155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.

14. Ishihara T, Haraguchi G, Kamiishi T, et al. Sensitive assessment of activity of Takayasu’s arteritis by pentraxin 3, a new biomarker. J Am Coll Cardiol. 2011 Apr 19;57(16): 1712-3. doi: 10.1016/j.jacc.2010.10.058.

15. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayas, s arteritis. Clin Exp Rheumatol. Jan-Feb 2011;29(1 Suppl 64):S86-91. Epub 2011 May 11.

16. Li Cavoli G, Mule G, Vallone MG, Caputo F. Takayasu’s disease effects on the kidneys: current perspectives. Int J Nephrol Renovasc Dis. 2018 Aug 15;11:225-33. doi: 10.2147/IJNRD.S146355. eCollection 2018.

17. Bicakcigil M, Aksu K, Kamali S, et al. Takayasu's arteritis in Turkey: clinical and angiographic features of 248 patients. Clin Exp Rheumatol. Jan-Feb 2009;27(1 Suppl 52):S59-64.

18. Karageorgaki ZT, Bertsias GK, Mavragani CP, et al. Takayasu Features in Greece. Clin Exp Rheumatol. Jan-Feb 2009; 27(1 Suppl 52):S33-9.

19. Moriwaki R, Noda M, Yajima M, et al. Clinical manifestations of Takayasu arteritis in India and Japan – new classification of angiographic findings. Angiology. 1997 May; 48(5):369-79. doi: 10.1177/000331979704800501.

20. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8): 1129-34. doi: 10.1002/art.1780330811.

21. Sharma BK, Jain S, Suri S, et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. doi: 10.1016/s0167-5273(96)88783-3.

22. Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996 Aug;54 Suppl:S155-63. doi: 10.1016/s0167-5273(96)02813-6.

23. Luqmani R. Evaluation of vasculitis disease activity in Europe. Eur J Intern Med. 2007;66(3):283-92.

24. Jefferson R, Roberts MD. Takayasu Arteritis Differential Diagnoses. http://emedicine.medscape.com/article/332378-differential.

25. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978 Jan; 57(1):27-35. doi: 10.1161/01.cir.57.1.27.

26. Nived O, Jonsen A, Bengtsson A, et al. High predictive value of Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol. 2002 Jul;29(7):1398-400.

27. Shostak NA, redaktor. Revmatologiya: uchebnoe posobie [Rheumatology: a textbook]. Moscow: GEOTAR-Media; 2012. 448 p.

28. Klippel DzhKh, Stoun DzhKh, Krofford DzhL, Uait PKh, editors. Revmaticheskie zabolevaniya. Tom 2 [Rheumatic diseases. Volume 2]. Moscow: GEOTAR-Media; 2011. 336 p.

29. Dreyer L, Faurschou M, Baslund B. A population-based study of Takayasu's arteritis in eastern Denmark. Clin Exp Rheumatol. Jan-Feb 2011;29(1 Suppl 64): S40-2. Epub 2011 May 11.

30. Urban Waern A, Andersson P, Hemmingsson A. Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology. 1983 May; 34(5):311-20. doi: 10.1177/000331978303400504.

31. Rodevand E, Skomsvoll JF, Wallenius M, et al. Takayau's arteritis. Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):173-6.

32. Watts R, Al-Taiar A, Mooney J, et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009 Aug; 48(8):1008-11. doi: 10.1093/rheumatology/kep153. Epub 2009 Jun 19.

33. Dadoniene J, Kirdaite G, Mackiewicz Z, et al. Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study. Ann Rheum Dis. 2005 Feb; 64(2):335-6. doi: 10.1136/ard.2004.022335.

34. Reinhold-Keller E, Herlyn K, WagnerBastmeyer R, et al. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005 Feb 15;53(1):93-9. doi:10.1002/art.20928.

35. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl. 1992;7:48-54. doi: 10.1007/BF01744544.

36. Toshihiko N. Current status of large and small vessel vasculitis in Japan. Int J Cardiol. 1996 Aug;54 Suppl:S91-8. doi: 10.1016/s0167-5273(96)88777-8.

37. El-Reshaid K, Varro J, al-Duwairi Q, Anim JT. Takayasu's arteritis in Kuwait. J Trop Med Hyg. 1995 Oct;98(5):299-305.

38. Hall S, Hunder G. Takayasu arteritis: a study of 32 North American patients. Medicine (Baltimore). 1985 Mar;64(2):89-99.

39. Bicakcigil M, Aksu K, Kamali S, et al. Takayasu's arteritis in Turkey: clinical and angiographic features of 248 patients. Clin Exp Rheumatol. Jan-Feb 2009;27(1 Suppl 52):S59-64.

40. Vanoli M, Daina E, Salvarani C, et al. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005 Feb 15;53(1): 100-7. doi: 10.1002/art.20922.

41. Karageorgaki Z, Bertsias GK, Mavragani CP, et al. Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol. 2009 Jan-Feb;27 (1 Suppl 52):S33-9.

42. Arnaud L, Haroche J, Limal N, et al. Takayasu arteritis in France: a single center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore). 2010 Jan;89(1):1-17. doi: 10.1097/MD.0b013e3181cba0a3.

43. Sharma BK, Sagar S, Singh AP, Suri S. Takayasu arteritis in India. Heart Vessels Suppl. 1992;7:37-43. doi: 10.1007/BF01744542.

44. Piyachon C, Suwanwela N. Takayasu arteritis in Thailand. Heart Vessels Suppl. 1992;7:60-7. doi: 10.1007/BF01744546.

45. Moriwaki R, Noda M, Yajima M, et al. Clinical Manifestations of Takayasu Arteritis in India and Japan. New Classification of Angiographic Findings. Angiology. 1997 May; 48(5):369-79. doi: 10.1177/000331979704800501.

46. Smitienko IO. Clinical variants of organ lesions, assessment of activity and prognosis of Takayasu arteritis. Diss. cand. med. sci. 2010.